Management of heparin-associated thrombocytopenia in extracorporeal membrane oxygenation

doi:10.3877/cma.j.issn.2096-1537.2020.02.010

Abstract

Abstract:

Heparin induced thrombocytopenia (HIT) is a non-hemorrhagic immune-related complication that occurs most frequently in the clinical application of heparin. The probability of occurrence of HIT is not high during the use of extracorporeal membrane oxygenation (ECMO), but it is extremely lethal. Therefore, it is extremely important to prevent the occurrence of HIT during the use of ECMO. In addition, being familiar with the treatment strategy for HIT and giving proper intervention early when this complication occurs are the keys to reducing the mortality of patients. This article briefly analyzes the management of heparin-related thrombocytopenia in extracorporeal membrane oxygenation.

Key words: Heparin, Thrombocytopenia, Extracorporeal membrane oxygenation, Prevention, Management

Hua Xu, Yongqiang Wang. Management of heparin-associated thrombocytopenia in extracorporeal membrane oxygenation[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2020, 06(02): 156-159.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2020.02.010

https://icu.cma-cmc.com.cn/EN/Y2020/V06/I02/156

References 33

1	Arepally GM. Heparin-induced thrombocytopenia[J]. Blood, 2017, 129(21): 2864-2872.
2	Joseph J, Rabbolini D, Enjeti AK, et al. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group[J]. Med J Aust, 2019, 210(11): 509-516.
3	Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia[J]. Blood Adv, 2018, 2(22): 3360-3392.
4	中国医师协会心血管内科医师分会血栓防治专业委员会《中华医学杂志》编辑委员会. 肝素诱导的血小板减少症中国专家共识(2017）[J]. 中华医学杂志, 2018, 98(6): 408-417.
5	Cavarocchi NC. Introduction to Extracorporeal Membrane Oxygenation[J]. Crit Care Clin, 2017, 33(4): 763-766.
6	Hill JD, O′Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286(12): 629-634.
7	Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome[J]. JAMA, 2009, 302(17): 1888-1895.
8	Pham T, Combes A, Rozé H, et al. Extracorporealmembrane oxygenation for pandemic influenza A (H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis[J]. Am J Respir Crit Care Med, 2013, 187: 276-85.
9	Cavarocchi NC. Introduction to Extracorporeal Membrane Oxygenation[J]. Crit Care Clin, 2017, 33(4): 763-766.
10	黑飞龙，龙村. 体外膜肺氧合并发症防治进展[J]. 中国体外循环杂志, 2007, 5(4): 250-252.
11	Pollak U. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants[J]. J Thromb Haemost, 2019, 17(10): 1608-1622.
12	Pollak U. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants[J]. Perfusion, 2018, 33(1_suppl): 7-17.
13	Cuker A, Arepally G, Crowther MA, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion[J]. J Thromb Haemost, 2010, 8(12): 2642-2650.
14	Younis M, Ya′qoub L, Ali Z, et al. Comparison of a clinical-laboratory algorithm, 4t and heparin-induced thrombocytopenia expert probability scores in the diagnosis of heparin-induced thrombocytopenia in the critical care setting[J]. Am J Blood Res, 2019, 9(3): 25-33.
15	Li S, Fan LK, Wang SJ, et al. Prospective evaluation of heparin-induced thrombocytopenia expert probability and 4T scores in Chinese patients with suspected heparin-induced thrombocytopenia[J]. Chin Med J (Engl), 2019, 132(12): 1441-1447.
16	Vayne C, Guery EA, Kizlik-Masson C, et al. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin- induced thrombocytopenia antibodies[J]. Br J Haematol, 2017, 179(5): 811-819.
17	Pandya KA, Johnson EG, Davis GA, et al. Serotonin release assay (SRA)-negative HIT: a newly recognized entity: implications for diagnosis and management[J]. Thromb Res, 2018, 172: 169-171
18	Warkentin TE, Nazy I, Sheppard JI, et al. Serotonin-release assay-negative heparin-induced thrombocytopenia[J]. Am J Hematol, 2020, 95(1): 38-47.
19	Fathi M. Heparin-induced thrombocytopenia (HIT): Identification and treatment Pathways[J]. Glob Cardiol Sci Pract, 2018, 2018(2): 15.
20	宋景春，刘树元，朱峰, 等. 中国成人重症患者血小板减少诊疗专家共识[J]. 解放军医学杂志, 2020, 45(2): 95-112.
21	Rougé A, Pelen F, Durand M, et al. Argatroban for an alternative anticoagulant in HIT during ECMO[J]. J Intensive Care, 2017, 5: 39.
22	Sin JH, Lopez ND. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration[J]. J Extra Corpor Technol, 2017, 49(2): 115-120.
23	Phillips MR, Khoury AI, Ashton RF, et al. The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution[J]. Anaesth Intensive Care, 2014, 42(1): 97-98.
24	Koster A, Niedermeyer J, Gummert J, et al. Low dose bivalirudin anticoagulation for lung transplantation with extracorporeal membrane oxygenation in a patient with acute heparin-induced thrombocytopenia[J]. Eur J Cardiothorac Surg, 2017, 51(5): 1009-1011.
25	Netley J, Roy J, Greenlee J, et al. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review[J]. J Extra Corpor Technol, 2018, 50(3): 161-166.
26	Pieri M, Agracheva N, Bonaveglio E, et al. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study[J]. J Cardiothorac Vasc Anesth, 2013, 27(1): 30-34.
27	Berei TJ, Lillyblad MP, Wilson KJ, et al. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation[J]. ASAIO J, 2018, 64(5): 623-629.
28	Macielak S, Burcham P, Whitson B, et al. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy[J]. Perfusion, 2019, 34(8): 671-678.
29	Netley J, Roy J, Greenlee J, et al. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review[J]. J Extra Corpor Technol, 2018, 50(3): 161-166.
30	Parlar AI, Sayar U, Cevirme D, et al. Successful use of fondaparinux in a patient with heparin-induced thrombocytopenia while on extracorporeal membrane oxygenation after mitral valve redo surgery[J]. Int J Artif Organs, 2014, 37(4): 344-347.
31	Bauer C, Vichova Z, Ffrench P, et al. Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism[J]. Anesth Analg, 2008, 106(4): 1101-1103,
32	Dager WE, Gosselin RC, Yoshikawa R, et al. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation[J]. Ann Pharmacother, 2004, 38(4): 598-601.
33	Balasubramanian SK, Tiruvoipati R, Chatterjee S, et al. Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener′s granulomatosis with heparin-induced thrombocytopenia[J]. ASAIO J, 2005, 51(4): 477-479.

[1]	Shun Chen, Ensheng Xue, Qin Ye. Value of PDCA cycle in continuous improvement of ultrasonic critical value management system [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 974-978.
[2]	Bohui Shi, Xiping Ding, Lian Wang, Rong Li, Pingli Guo, Jing Qi, Yao Chen, Na Hao, Yu Ren. Summary of best evidences for prevention and treatment of subcutaneous seroma after breast cancer surgery [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 277-284.
[3]	Haoyuan Yang, Jie Gong, Qingwei Zou, Hang Ruan. Current research status on adverse pregnancy outcomes of maternal and infant in pregnant women with asthma [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 522-529.
[4]	Chenxi Ran, Rufei Shen, Mingyu Liao, Qian Liao, Ling Zhou, Yuling Zhang, Min Long. Treatment and management of pituitary tumor during pregnancy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 487-491.
[5]	Roumei Cai, Jiemei Zeng, Weili Huang, Wenmin Xie, Yandan Liu, Manjun Wu, Chuyan Cai. Clinical research of QC circle intervention to reduce the incidence of catheter related infection during femoral vein catheterization in burn wounds [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(05): 399-404.
[6]	Min Wang, Jiabin Jiang, Maoxin Li. Effect of early-warning education combined with personalized pain management on patients undergoing inguinal hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 764-767.
[7]	Qingqing Zhu, Zhenqi Wei. Application value of self-efficacy management during perioperative period in patients with inguinal hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 773-777.
[8]	Xiaolan Min, Jiechao Zhou, Zhentian Chen. Effect of health management combined with psychological intervention in children after laparoscopic inguinal hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(05): 657-661.
[9]	Junyong Ma, Yizhou Wang, Xifeng Li. Brief discussion on prevention and control strategy for bleeding in laparoscopic hepatectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 495-498.
[10]	Cuiping Li, Xiaoyan Chen, Shiyu Qian, Huizhu Lin, Caihui Zeng, Li Yang, Jianxi Lu. Effects of different anticoagulant preservation solutions on the proliferation and killing effects of NK cells cultured in umbilical cord blood [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 572-576.
[11]	. Expert consensus on perioperative management of day surgery for hip and knee arthroplasty in China [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(06): 321-332.
[12]	Jun Wang, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Libin Suo, Jun Chen, chengli Miao, Chenghua Luo. Retrospective analysis of anesthesia management of massive transfusion patients undergoing retroperitoneal tumor resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 844-849.
[13]	Libin Suo, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Jun Wang, Jun Chen, Chengli Miao, Chenghua Luo. Key points of anesthesia management and prognostic factors in patients undergoing primary retroperitoneal paraganglioma resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 771-776.
[14]	Guoxiao Xie, Lingxia Zhao, Xuehua Xue. Application of chronic disease management model in diabetes community management [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 587-590.
[15]	Xuping Zhang, Jiacheng Liu, Ge Zhang, Yanjiao Du, Shao Li, Dandan Shang, Hao Wang, Yan Li, Zhihui Duan. CYP2C19 gene polymorphism combined with thromboelastogram-guided antiplatelet therapy for patients with the large artery atherosclerosis and non-disabling ischemic cerebrovascular events (NICE) [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 477-481.

Please choose a citation manager

Content to export